Validation of the sarcopenia index to assess muscle mass in the critically ill: A novel application of kidney function markers
- 1 June 2019
- journal article
- research article
- Published by Elsevier BV in Clinical Nutrition
- Vol. 38 (3), 1362-1367
- https://doi.org/10.1016/j.clnu.2018.05.031
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Low skeletal muscle area is a risk factor for mortality in mechanically ventilated critically ill patientsCritical Care, 2014
- Frailty and outcomes after implantation of left ventricular assist device as destination therapyThe Journal of Heart and Lung Transplantation, 2013
- The Prevalence of Sarcopenia in Patients With Respiratory Failure Classified as Normally Nourished Using Computed Tomography and Subjective Global AssessmentJournal of Parenteral and Enteral Nutrition, 2013
- Cancer Cachexia in the Age of Obesity: Skeletal Muscle Depletion Is a Powerful Prognostic Factor, Independent of Body Mass IndexJournal of Clinical Oncology, 2013
- Creatinine/cystatin C ratio as a surrogate marker of residual muscle mass in amyotrophic lateral sclerosisNeurology and Clinical Neuroscience, 2013
- Skeletal muscle predicts ventilator-free days, ICU-free days, and mortality in elderly ICU patientsCritical Care, 2013
- Glomerular filtration rate estimation: performance of serum cystatin C-based prediction equationscclm, 2011
- Sarcopenia: European consensus on definition and diagnosisAge and Ageing, 2010
- Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based studyThe Lancet Oncology, 2008
- A global clinical measure of fitness and frailty in elderly peopleCMAJ : Canadian Medical Association Journal, 2005